Does Your Health Abandonee Know Best?

Have you ever wanted to try a certain medication or treatment, only to discover that it wouldn’t be covered by insurance? That’s because insurers follow a practice of step therapy to help control costs.

Step medical care, conjointly referred to as “fail 1st,” requires a person to “fail” on one or more drug approved by the U.S. Food and Drug Administration (FDA) before the insurance firm can cowl another medication which will be most well-liked by the person or their health care supplier. Some insurers also require that a person tries and fails on one or more prescription medications not approved by the FDA for the condition being treated, a practice known as “forcedoff-label prescribing.”

Off-label prescribing occurs when a physician prescribes a drug that is FDA-approved for a use other than the condition for which it is being prescribed. For example, medicines approved to treat depression may be used to treat chronic pain.

The practice is legal and commonly practiced. In fact, one out of five prescriptions is written for off-label use, according to the Agency for Healthcare Research and Quality. Some, clearly, argue that step medical care and, notably, forced off-label prescribing transfers decision-making from health care professionals to insurers.Â

Here is an example of how a typical forced off-label prescription scenario could play out.

Condition: Moderate to severe hot flashes
Desired medication: Newly FDA-approved, nonhormonal prescription medication called Brisdelle.
Forced off-label process: The only other approved treatment for hot flashes is hormone therapy, which some women are unable or unwilling to use. Insurance will require women to try and fail on non-approved FDA medications before trying Brisdelle, which restricts their options and may delay their relief. 

What can you do? If you are concerned about being forced to try medications that are not FDA-approved for treating hot flashes (or other conditions) or you want to help ensure prompt access to medications that are FDA-approved, contact your insurer, legislators, state insurance commission and state attorney general’s office to let them know that forced off-label prescribing is not acceptable—and may not be in the best interest of your health. 

There is hope. Three states—Maryland, New Hampshire and Vermont—recently passed laws restricting forced off-label prescribing to protect patients and return decision-making to the health care providers.